Evidence map›Paper›PMID 32893709›Full record

ArticleGut microbes2020

Metabolite profiling reveals the interaction of chitin-glucan with the gut microbiota.

Julie Rodriguez, Audrey M Neyrinck, Zhengxiao Zhang, Benjamin Seethaler, Julie-Anne Nazare, Cándido Robles Sánchez, Martin Roumain, Giulio G Muccioli, Laure B Bindels, Patrice D Cani and 5 more

Open access · goldAbstract read
In one paragraph

Article in Gut microbes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Metabolic signature ofEuropean journal of nutrition · 2023
    Trial
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Effect ofFrontiers in microbiology · 2025
    Article
  18. A Synbiotic Combining Chitin-Glucan andInternational journal of molecular sciences · 2024
    Article
  19. Efficacy and tolerability of chitin-glucan combined with simethicone (GASTRAPWorld journal of gastrointestinal pharmacology and therapeutics · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 5 countries.

Julie RodriguezMetabolism and Nutrition Research Group, Louvain Drug Research Institute, UCLouvain, Université Catholique de Louvain , Brussels, Belgium.ORCID 0000-0002-8271-3893
Audrey M NeyrinckMetabolism and Nutrition Research Group, Louvain Drug Research Institute, UCLouvain, Université Catholique de Louvain , Brussels, Belgium.ORCID 0000-0002-9435-3338
Zhengxiao ZhangDepartment of Medicine, University of Alberta , Edmonton, Canada.ORCID 0000-0002-6977-4309
Benjamin SeethalerInstitute of Nutritional Medicine, University of Hohenheim , Stuttgart, Germany.ORCID 0000-0003-1889-8085
Julie-Anne NazareRhône-Alpes Research Center for Human Nutrition, Université-Lyon, CarMeN Laboratory, Hospices Civils de Lyon , Lyon, France.ORCID 0000-0003-3545-3264
Cándido Robles SánchezMetabolism and Nutrition Research Group, Louvain Drug Research Institute, UCLouvain, Université Catholique de Louvain , Brussels, Belgium.
Martin RoumainBioanalysis and Pharmacology of Bioactive Lipids Research Group, Louvain Drug Research Institute, UCLouvain, Université Catholique de Louvain , Brussels, Belgium.ORCID 0000-0001-8915-795X
Giulio G MuccioliBioanalysis and Pharmacology of Bioactive Lipids Research Group, Louvain Drug Research Institute, UCLouvain, Université Catholique de Louvain , Brussels, Belgium.ORCID 0000-0002-1600-9259
Laure B BindelsMetabolism and Nutrition Research Group, Louvain Drug Research Institute, UCLouvain, Université Catholique de Louvain , Brussels, Belgium.ORCID 0000-0003-3747-3234
Patrice D CaniMetabolism and Nutrition Research Group, Louvain Drug Research Institute, UCLouvain, Université Catholique de Louvain , Brussels, Belgium.ORCID 0000-0003-2040-2448
Véronique MaquetKitoZyme, Parc Industriel des Hauts-Sart , Herstal, Belgium.
Martine LavilleRhône-Alpes Research Center for Human Nutrition, Université-Lyon, CarMeN Laboratory, Hospices Civils de Lyon , Lyon, France.ORCID 0000-0002-6252-9853
Stephan C BischoffInstitute of Nutritional Medicine, University of Hohenheim , Stuttgart, Germany.ORCID 0000-0003-2614-5948
Jens WalterDepartment of Agricultural, Food & Nutritional Science and Department of Biological Sciences, University of Alberta , Edmonton, Canada.ORCID 0000-0003-1754-172X
Nathalie M DelzenneMetabolism and Nutrition Research Group, Louvain Drug Research Institute, UCLouvain, Université Catholique de Louvain , Brussels, Belgium.ORCID 0000-0003-2115-6082
UCLouvain · BEHospices Civils de Lyon · FRUniversity of Alberta · CAUniversity of Hohenheim · DEKitoZyme (Belgium) · BEWalloon Excellence in Lifesciences and Biotechnology · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dietary fibers are considered beneficial nutrients for health. Current data suggest that their interaction with the gut microbiota largely contributes to their physiological effects. In this context, chitin-glucan (CG) improves metabolic disorders associated with obesity in mice, but its effect on gut microbiota has never been evaluated in humans. This study explores the effect of a 3-week intervention with CG supplementation in healthy individuals on gut microbiota composition and bacterial metabolites. CG was given to healthy volunteers (n = 15) for three weeks as a supplement (4.5 g/day). Food diary, visual analog and Bristol stool form scales and a "quality of life" survey were analyzed. Among gut microbiota-derived metabolites, bile acids (BA), long- and short-chain fatty acids (LCFA, SCFA) profiling were assessed in stool samples. The gut microbiota (primary outcome) was analyzed by Illumina sequencing. A 3-week supplementation with CG is well tolerated in healthy humans. CG induces specific changes in the gut microbiota composition, with

Indexed as

Gastrointestinal MicrobiomeAdolescentAdultBacteriaBile Acids and SaltsBiomarkersChitinDietary SupplementsFatty Acids, VolatileFecesFemaleGlucansHumansIntestinal MucosaMaleYoung AdultBile Acids and SaltsBiomarkersChitinFatty Acids, VolatileGlucansbile acidschitin-glucanfiberGut microbiotaSCFA

Identifiers

PMID32893709
PMCPMC7524357
OpenAlexW3083596255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.